|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
DE102005046490A1
(de)
|
2005-09-28 |
2007-03-29 |
Johannes-Gutenberg-Universität Mainz |
Modifikationen von RNA, die zu einer erhöhten Transkriptstabilität und Translationseffizienz führen
|
|
US9732131B2
(en)
|
2006-02-27 |
2017-08-15 |
Calviri, Inc. |
Identification and use of novopeptides for the treatment of cancer
|
|
RU2012111349A
(ru)
|
2009-08-24 |
2013-10-27 |
Байлор Колледж Оф Медсин |
Генерация линий ctl со специфичностью против множества опухолевых антигенов или множества вирусов
|
|
DK3023788T3
(da)
*
|
2010-05-14 |
2020-04-27 |
Massachusetts Gen Hospital |
Sammensætninger af tumorspecifikke neoantigener til anvendelse ved behandling af tumorer
|
|
LT3473267T
(lt)
*
|
2011-05-24 |
2021-11-25 |
BioNTech SE |
Individualizuotos vakcinos nuo vėžio
|
|
PL2714071T3
(pl)
*
|
2011-05-24 |
2019-12-31 |
Biontech Rna Pharmaceuticals Gmbh |
Zindywidualizowane szczepionki przeciwrakowe
|
|
EP2757153B1
(en)
*
|
2011-08-02 |
2019-07-03 |
The University of Tokyo |
Method for assessing myelodysplastic syndrome or myeloid tumor predisposition, polypeptide and antibody therefor, and candidate screening method for therapeutic drug or prophylactic drug therefor
|
|
US20130164746A1
(en)
*
|
2011-09-29 |
2013-06-27 |
Davide Rossi |
Mutations in SF3B1 and Chronic Lymphocytic Leukemia
|
|
WO2013086464A1
(en)
*
|
2011-12-07 |
2013-06-13 |
The Broad Institute, Inc. |
Markers associated with chronic lymphocytic leukemia prognosis and progression
|
|
GB201121308D0
(en)
|
2011-12-12 |
2012-01-25 |
Cell Medica Ltd |
Process
|
|
DK2812431T3
(da)
|
2012-02-09 |
2019-10-14 |
Baylor College Medicine |
Peptidblandinger til generering af multivirale ctl'er med bred specificitet
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
WO2013177593A2
(en)
|
2012-05-25 |
2013-11-28 |
Phosimmune, Inc. |
Identification of mhc class i phospho-peptide antigens from breast cancer utilizing shla technology and complementary enrichment strategies
|
|
MX364370B
(es)
*
|
2012-07-12 |
2019-04-24 |
Persimmune Inc |
Vacunas contra el cancer personalizadas y terapias de celulas inmunes adoptivas.
|
|
GB201214007D0
(en)
*
|
2012-08-07 |
2012-09-19 |
Scancell Ltd |
Anti-tumour immune responses to modified self-epitopes
|
|
WO2014036562A2
(en)
*
|
2012-08-31 |
2014-03-06 |
University Of Virginia Patent Foundation |
Target peptides for immunotherapy and diagnostics
|
|
CA2883673A1
(en)
|
2012-09-05 |
2014-03-13 |
University Of Virginia Patent Foundation |
Target peptides for colorectal cancer therapy and diagnostics
|
|
US10501801B2
(en)
|
2012-09-28 |
2019-12-10 |
University Of Connecticut |
Identification of tumor-protective epitopes for the treatment of cancers
|
|
US10155031B2
(en)
|
2012-11-28 |
2018-12-18 |
Biontech Rna Pharmaceuticals Gmbh |
Individualized vaccines for cancer
|
|
GB2508414A
(en)
*
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
SG10201710472PA
(en)
|
2013-02-22 |
2018-02-27 |
Curevac Ag |
Combination of vaccination and inhibition of the pd-1 pathway
|
|
BR122021025267B1
(pt)
|
2013-02-22 |
2023-12-05 |
Curevac Ag |
Partes de kit e composição farmacêutica compreendendo um inibidor da via de pd-1
|
|
CA2906514C
(en)
|
2013-03-14 |
2021-07-27 |
Jonathan Schneck |
Nanoscale artificial antigen presenting cells
|
|
CN118750591A
(zh)
*
|
2013-04-07 |
2024-10-11 |
博德研究所 |
用于个性化瘤形成疫苗的组合物和方法
|
|
WO2014180490A1
(en)
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
|
WO2015085147A1
(en)
|
2013-12-05 |
2015-06-11 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
EP3076992B1
(en)
*
|
2013-12-06 |
2022-04-06 |
The Broad Institute, Inc. |
Formulations for neoplasia vaccines
|
|
CA2934073A1
(en)
*
|
2013-12-20 |
2015-06-25 |
The Broad Institute, Inc. |
Combination therapy with neoantigen vaccine
|
|
CA2935214A1
(en)
*
|
2014-01-02 |
2015-07-09 |
Memorial Sloan Kettering Cancer Center |
Determinants of cancer response to immunotherapy
|
|
US10307472B2
(en)
|
2014-03-12 |
2019-06-04 |
Curevac Ag |
Combination of vaccination and OX40 agonists
|
|
WO2015160928A2
(en)
|
2014-04-15 |
2015-10-22 |
University Of Virginia Patent Foundation |
Isolated t cell receptors and methods of use therefor
|
|
JP2017528143A
(ja)
*
|
2014-09-10 |
2017-09-28 |
ザ ユニバーシティ オブ コネチカット |
癌の治療のための免疫防御ネオエピトープ同定
|
|
US10564165B2
(en)
*
|
2014-09-10 |
2020-02-18 |
Genentech, Inc. |
Identification of immunogenic mutant peptides using genomic, transcriptomic and proteomic information
|
|
US11338026B2
(en)
|
2014-09-10 |
2022-05-24 |
The University Of Connecticut |
Identification of immunologically protective neo-epitopes for the treatment of cancers
|
|
WO2016040900A1
(en)
*
|
2014-09-14 |
2016-03-17 |
Washington University |
Personalized cancer vaccines and methods therefor
|
|
CA3017170C
(en)
|
2014-09-17 |
2021-03-23 |
The Johns Hopkins University |
Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells
|
|
HRP20211540T2
(hr)
*
|
2014-09-17 |
2022-05-13 |
Io Biotech Aps |
Sastavi cjepiva koji sadrže triptofan 2,3-dioksigenazu ili njene fragmente
|
|
WO2016045732A1
(en)
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
CA2963364A1
(en)
|
2014-10-02 |
2016-04-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of isolating t cells having antigenic specificity for a cancer-specific mutation
|
|
EP4029508A1
(en)
*
|
2014-10-10 |
2022-07-20 |
Idera Pharmaceuticals, Inc. |
Treatment of cancer using tlr9 agonists and checkpoint inhibitors
|
|
MA40737A
(fr)
|
2014-11-21 |
2017-07-04 |
Memorial Sloan Kettering Cancer Center |
Déterminants de la réponse d'un cancer à une immunothérapie par blocage de pd-1
|
|
ES3049406T3
(en)
|
2014-12-19 |
2025-12-16 |
Broad Inst Inc |
Methods for profiling the t-cell-receptor repertoire
|
|
EP3234193B1
(en)
|
2014-12-19 |
2020-07-15 |
Massachusetts Institute of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
WO2016128060A1
(en)
*
|
2015-02-12 |
2016-08-18 |
Biontech Ag |
Predicting t cell epitopes useful for vaccination
|
|
AU2016238290B9
(en)
*
|
2015-03-25 |
2019-06-13 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of biomacromolecule agents
|
|
CA2987730C
(en)
*
|
2015-04-08 |
2020-02-18 |
Nantomics, Llc |
Cancer neoepitopes
|
|
WO2016172722A1
(en)
|
2015-04-23 |
2016-10-27 |
Nantomics, Llc |
Cancer neoepitopes
|
|
GB201507030D0
(en)
|
2015-04-24 |
2015-06-10 |
Immatics Biotechnologies Gmbh |
Immunotherapy against lung cancers, in particular NSCLC
|
|
CN107750278B
(zh)
*
|
2015-04-27 |
2023-10-03 |
癌症研究技术有限公司 |
治疗癌症的方法
|
|
US10544392B2
(en)
|
2015-05-01 |
2020-01-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood
|
|
MX392028B
(es)
|
2015-05-13 |
2025-03-04 |
Agenus Inc |
Vacunas para el tratamiento y prevención del cáncer.
|
|
PE20180670A1
(es)
*
|
2015-05-20 |
2018-04-19 |
Broad Inst Inc |
Neoantigenos compartidos
|
|
TW202241500A
(zh)
*
|
2015-06-09 |
2022-11-01 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
|
JP2018524008A
(ja)
|
2015-07-14 |
2018-08-30 |
パーソナル ジノーム ダイアグノスティクス， インコーポレイテッド |
ネオアンチゲン分析
|
|
MA42543A
(fr)
|
2015-07-30 |
2018-06-06 |
Modernatx Inc |
Arn épitope peptidiques concatémériques
|
|
GB201516047D0
(en)
*
|
2015-09-10 |
2015-10-28 |
Cancer Rec Tech Ltd |
Method
|
|
JP6999941B2
(ja)
*
|
2015-09-18 |
2022-02-10 |
ベイラー カレッジ オブ メディスン |
病原体からの免疫原性抗原同定および臨床的有効性との相関
|
|
WO2017059902A1
(en)
|
2015-10-07 |
2017-04-13 |
Biontech Rna Pharmaceuticals Gmbh |
3' utr sequences for stabilization of rna
|
|
CN108701173A
(zh)
|
2015-10-12 |
2018-10-23 |
南托米克斯有限责任公司 |
用于发现预测对检查点抑制剂敏感的msi和新表位的系统、组合物和方法
|
|
KR20240010089A
(ko)
|
2015-10-12 |
2024-01-23 |
난토믹스, 엘엘씨 |
네오에피토프의 반복적 발견 및 이에 대한 적응성 면역치료 및 방법
|
|
MX387275B
(es)
|
2015-10-12 |
2025-03-18 |
Nantomics Llc |
Neoepítopos virales y sus usos
|
|
KR20250161050A
(ko)
*
|
2015-10-12 |
2025-11-14 |
난토믹스, 엘엘씨 |
바이러스성 암 네오에피토프를 위한 조성물 및 방법
|
|
JP2018532777A
(ja)
*
|
2015-10-22 |
2018-11-08 |
モデルナティーエックス， インコーポレイテッド |
癌ワクチン
|
|
IL290309B2
(en)
|
2015-11-06 |
2024-04-01 |
Ventana Med Syst Inc |
Representative diagnostics
|
|
TWI733719B
(zh)
|
2015-12-07 |
2021-07-21 |
美商河谷控股Ｉｐ有限責任公司 |
改善的組合物及用於新表位之病毒遞送的方法及其應用
|
|
EP3389630B1
(en)
|
2015-12-16 |
2023-11-08 |
Gritstone bio, Inc. |
Neoantigen identification, manufacture, and use
|
|
JP2019505579A
(ja)
*
|
2015-12-23 |
2019-02-28 |
ムーンショット ファーマ エルエルシー |
免疫応答を誘導するための方法
|
|
CA3008437A1
(en)
|
2016-01-08 |
2017-07-13 |
Vaccibody As |
Therapeutic anticancer neoepitope vaccine
|
|
US20170224796A1
(en)
|
2016-02-05 |
2017-08-10 |
Xeme Biopharma Inc. |
Therapeutic Cancer Vaccine Containing Tumor-Associated Neoantigens and Immunostimulants in a Delivery System
|
|
CA3014252A1
(en)
*
|
2016-02-12 |
2017-08-17 |
Nantomics, Llc |
High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies
|
|
WO2017143092A1
(en)
|
2016-02-19 |
2017-08-24 |
Nant Holdings Ip, Llc |
Methods of immunogenic modulation
|
|
CN105720176A
(zh)
*
|
2016-02-19 |
2016-06-29 |
京东方科技集团股份有限公司 |
一种胶囊量子点和发光二极管、制备方法及显示装置
|
|
US11154597B2
(en)
*
|
2016-03-24 |
2021-10-26 |
Nantcell, Inc. |
Sequence arrangements and sequences for neoepitope presentation
|
|
WO2017177207A1
(en)
*
|
2016-04-07 |
2017-10-12 |
Bostongene, Llc |
Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines
|
|
WO2017180769A1
(en)
*
|
2016-04-13 |
2017-10-19 |
Capten Therapeutics Inc. |
Small molecules for immunogenic treatment of cancer
|
|
WO2017223085A2
(en)
|
2016-06-20 |
2017-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of biomacromolecule agents
|
|
WO2018005276A1
(en)
*
|
2016-06-29 |
2018-01-04 |
The Johns Hopkins University |
Neoantigens as targets for immunotherapy
|
|
ES3032115T3
(en)
|
2016-07-13 |
2025-07-15 |
Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
LT3488443T
(lt)
*
|
2016-07-20 |
2021-10-25 |
BioNTech SE |
Neoepitopų, kaip ligai specifinių taikinių, parinkimas padidinto efektyvumo terapijai
|
|
KR20190031573A
(ko)
*
|
2016-08-02 |
2019-03-26 |
난트셀, 인크. |
수지상 세포들의 형질주입 및 그 방법들(transfection of dendritic cells and methods therefor)
|
|
WO2018045249A1
(en)
*
|
2016-08-31 |
2018-03-08 |
Medgenome, Inc. |
Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore
|
|
US10350280B2
(en)
|
2016-08-31 |
2019-07-16 |
Medgenome Inc. |
Methods to analyze genetic alterations in cancer to identify therapeutic peptide vaccines and kits therefore
|
|
US10463686B2
(en)
|
2016-09-15 |
2019-11-05 |
Idera Pharmaceuticals, Inc. |
Immune modulation with TLR9 agonists for cancer treatment
|
|
CA3037882A1
(en)
*
|
2016-09-23 |
2018-03-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
|
|
WO2018071796A2
(en)
*
|
2016-10-13 |
2018-04-19 |
The Johns Hopkins University |
Compositions and methods for identifying functional anti-tumor t cell responses
|
|
CA3041068A1
(en)
*
|
2016-10-18 |
2018-04-26 |
Regents Of The University Of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
US20190321481A1
(en)
|
2016-11-11 |
2019-10-24 |
Nantbio, Inc. |
Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms
|
|
JP2020507557A
(ja)
|
2016-12-01 |
2020-03-12 |
ナントミクス，エルエルシー |
腫瘍抗原性の処理および提示
|
|
EP3574116A1
(en)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
KR20190120233A
(ko)
*
|
2017-02-01 |
2019-10-23 |
모더나티엑스, 인크. |
Rna 암 백신
|
|
EP3576780A1
(en)
|
2017-02-01 |
2019-12-11 |
Modernatx, Inc. |
Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptides
|
|
EP3601536A4
(en)
|
2017-03-20 |
2021-01-13 |
Genocea Biosciences, Inc. |
TREATMENT PROCESSES
|
|
WO2018183544A1
(en)
*
|
2017-03-31 |
2018-10-04 |
Dana-Farber Cancer Institute, Inc. |
Method for identification of retained intron tumor neoantigens from patient transcriptome
|
|
CN118370809A
(zh)
|
2017-04-03 |
2024-07-23 |
百欧恩泰美国公司 |
蛋白质抗原及其用途
|
|
CN110650750A
(zh)
|
2017-04-04 |
2020-01-03 |
阿维迪科技公司 |
基于肽的疫苗、其制造方法及其用于诱导免疫应答的用途
|
|
JP7217711B2
(ja)
*
|
2017-04-19 |
2023-02-03 |
グリットストーン バイオ インコーポレイテッド |
新生抗原の特定、製造、及び使用
|
|
SG11201909882SA
(en)
|
2017-04-24 |
2019-11-28 |
Nantcell Inc |
Targeted neoepitope vectors and methods therefor
|
|
TW201907937A
(zh)
|
2017-05-08 |
2019-03-01 |
美商葛利史東腫瘤科技公司 |
阿爾法病毒新抗原載體
|
|
WO2018209145A1
(en)
|
2017-05-10 |
2018-11-15 |
The Broad Institute, Inc. |
Methods and compositions for determination of mutations in single replication events
|
|
WO2018209324A2
(en)
|
2017-05-11 |
2018-11-15 |
The Broad Institute, Inc. |
Methods and compositions of use of cd8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof
|
|
US20200276285A1
(en)
|
2017-06-02 |
2020-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
A method to create personalized cancer vaccines
|
|
WO2018224166A1
(en)
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
JP7334124B2
(ja)
*
|
2017-06-21 |
2023-08-28 |
トランジェーヌ |
個別化ワクチン
|
|
US12049643B2
(en)
|
2017-07-14 |
2024-07-30 |
The Broad Institute, Inc. |
Methods and compositions for modulating cytotoxic lymphocyte activity
|
|
SG11202000425QA
(en)
|
2017-07-21 |
2020-02-27 |
Berkeley Lights Inc |
Antigen-presenting synthetic surfaces, covalently functionalized surfaces, activated t cells, and uses thereof
|
|
EP3658683A4
(en)
|
2017-07-25 |
2021-04-21 |
California Institute of Technology |
DISCOVERY OF TROGOCYTOSIS-MEDIATED EPITOPIA
|
|
WO2019036043A2
(en)
*
|
2017-08-16 |
2019-02-21 |
Medgenome Inc. |
METHOD FOR GENERATING A COCKTAIL OF PERSONALIZED ANTICANCER VACCINES FROM TUMOR DERIVED GENETIC MODIFICATIONS FOR THE TREATMENT OF CANCER
|
|
US12025615B2
(en)
|
2017-09-15 |
2024-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
|
CA3076918A1
(en)
*
|
2017-10-02 |
2019-04-11 |
Curematch, Inc. |
Method of prediction of tumor-derived neo-peptide antigenicity and/or immunogenicity using mutational signature patterns
|
|
AU2018345715A1
(en)
*
|
2017-10-06 |
2020-05-21 |
The Wistar Institute Of Anatomy And Biology |
DNA monoclonal antibodies targeting CTLA-4 for the treatment and prevention of cancer
|
|
JP7227237B2
(ja)
|
2017-10-10 |
2023-02-21 |
グリットストーン バイオ インコーポレイテッド |
ホットスポットを利用した新生抗原の特定
|
|
AU2018361561C1
(en)
*
|
2017-11-06 |
2025-07-03 |
Ludwig Institute For Cancer Research Ltd |
Method for expansion of lymphocytes
|
|
US20210154277A1
(en)
*
|
2017-11-07 |
2021-05-27 |
Nektar Therapeutics |
Immunotherapeutic combination for treating cancer
|
|
CA3081840A1
(en)
|
2017-11-08 |
2019-05-16 |
Neon Therapeutics, Inc. |
T cell manufacturing compositions and methods
|
|
CN111630602A
(zh)
|
2017-11-22 |
2020-09-04 |
磨石肿瘤生物技术公司 |
减少新抗原的接合表位呈递
|
|
CN109682978B
(zh)
*
|
2017-11-30 |
2020-07-03 |
四川康德赛医疗科技有限公司 |
一种肿瘤突变肽mhc亲和力预测方法及其应用
|
|
WO2019126186A1
(en)
|
2017-12-18 |
2019-06-27 |
Neon Therapeutics, Inc. |
Neoantigens and uses thereof
|
|
AU2019205330B2
(en)
|
2018-01-04 |
2025-09-11 |
Iconic Therapeutics Llc |
Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
|
|
EP3743102A1
(en)
|
2018-01-26 |
2020-12-02 |
Nantcell, Inc. |
Compositions and methods for combination cancer vaccine and immunologic adjuvant therapy
|
|
WO2019147921A1
(en)
|
2018-01-26 |
2019-08-01 |
Nantcell, Inc. |
Rapid verification of virus particle production for a personalized vaccine
|
|
CN108491689B
(zh)
*
|
2018-02-01 |
2019-07-09 |
杭州纽安津生物科技有限公司 |
基于转录组的肿瘤新抗原鉴定方法
|
|
TW202000693A
(zh)
*
|
2018-02-27 |
2020-01-01 |
美商葛利史東腫瘤科技公司 |
利用泛對偶基因（pan-allele）模型之新抗原鑑別
|
|
CA3096909A1
(en)
|
2018-04-26 |
2019-10-31 |
Agenus Inc. |
Heat shock protein-binding peptide compositions and methods of use thereof
|
|
WO2019227106A1
(en)
*
|
2018-05-25 |
2019-11-28 |
The Wistar Institute |
Tumor-specific neoantigens and methods of using the same
|
|
EP3806888B1
(en)
|
2018-06-12 |
2024-01-31 |
Obsidian Therapeutics, Inc. |
Pde5 derived regulatory constructs and methods of use in immunotherapy
|
|
JP7534962B2
(ja)
|
2018-06-19 |
2024-08-15 |
ビオンテック ユーエス インコーポレイテッド |
ネオ抗原およびその使用
|
|
EP3827262A1
(en)
|
2018-07-26 |
2021-06-02 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for breast cancer
|
|
IL321690A
(en)
|
2018-07-26 |
2025-08-01 |
Curevac Netherlands B V |
Cancer vaccines for uterine cancer
|
|
US20210213116A1
(en)
|
2018-07-26 |
2021-07-15 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for kidney cancer
|
|
WO2020022902A1
(en)
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Cancer vaccines for colorectal cancer
|
|
WO2020022897A1
(en)
*
|
2018-07-26 |
2020-01-30 |
Frame Pharmaceuticals B.V. |
Method of preparing subject-specific immunogenic compositions based on a neo open-reading-frame peptide database
|
|
US20210252123A1
(en)
|
2018-07-26 |
2021-08-19 |
Frame Pharmaceuticals B.V. |
ARID1A, CDKN2A, KMT2B, KMT2D, TP53 and PTEN VACCINES FOR CANCER
|
|
CN109021062B
(zh)
*
|
2018-08-06 |
2021-08-20 |
倍而达药业（苏州）有限公司 |
一种肿瘤新抗原的筛选方法
|
|
KR20210052511A
(ko)
|
2018-08-31 |
2021-05-10 |
가던트 헬쓰, 인크. |
무세포 dna에서의 미세부수체 불안정성 검출
|
|
GB201815041D0
(en)
|
2018-09-14 |
2018-10-31 |
Scancell Ltd |
Epitopes
|
|
TW202028224A
(zh)
|
2018-09-17 |
2020-08-01 |
德商英麥提克生物技術股份有限公司 |
B*44限制肽在抗癌免疫治療的用途和相關方法
|
|
CN112996905A
(zh)
|
2018-09-21 |
2021-06-18 |
伯克利之光生命科技公司 |
功能化的孔板、其制备和使用方法
|
|
MX2021003654A
(es)
|
2018-09-27 |
2021-05-28 |
Nykode Therapeutics AS |
Metodo para seleccionar neoepitopes.
|
|
AU2019362009A1
(en)
|
2018-10-18 |
2021-06-03 |
Berkeley Lights, Inc. |
Proto-antigen-presenting synthetic surfaces, activated t cells, and uses thereof
|
|
US20200188435A1
(en)
|
2018-11-08 |
2020-06-18 |
Nexlmmune, Inc. |
T cell compositions with improved phenotypic properties
|
|
WO2020131586A2
(en)
|
2018-12-17 |
2020-06-25 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
CN109706065A
(zh)
*
|
2018-12-29 |
2019-05-03 |
深圳裕策生物科技有限公司 |
肿瘤新生抗原负荷检测装置及存储介质
|
|
US20200291355A1
(en)
|
2019-02-20 |
2020-09-17 |
Rubius Therapeutics, Inc. |
Engineered erythroid cells including loadable antigen-presenting polypeptides and methods of use
|
|
CN111621564B
(zh)
*
|
2019-02-28 |
2022-03-25 |
武汉大学 |
一种鉴定有效肿瘤新抗原的方法
|
|
US12427195B1
(en)
*
|
2019-03-11 |
2025-09-30 |
La Jolla Institute For Immunology |
Methods of neoantigen identification
|
|
WO2020185010A1
(ko)
*
|
2019-03-12 |
2020-09-17 |
(주)신테카바이오 |
인공지능모델기반 분자동역학 빅데이터를 활용한 신생항원 면역치료정보 제공 시스템 및 방법
|
|
WO2020227233A2
(en)
*
|
2019-05-03 |
2020-11-12 |
Richard Guilhem |
Neoantigens in cancer
|
|
WO2020227255A1
(en)
*
|
2019-05-06 |
2020-11-12 |
The Regents Of The University Of Michigan |
Targeted therapy
|
|
IL288283B2
(en)
|
2019-05-30 |
2025-05-01 |
Gritstone Bio Inc |
Modified adenovirus
|
|
CN112011833B
(zh)
*
|
2019-05-30 |
2024-04-26 |
上海桀蒙生物技术有限公司 |
筛选和分离肿瘤新生抗原的方法
|
|
CN110322925B
(zh)
*
|
2019-07-18 |
2021-09-03 |
杭州纽安津生物科技有限公司 |
一种预测融合基因产生新生抗原的方法
|
|
CN110706747B
(zh)
*
|
2019-09-17 |
2021-09-07 |
北京橡鑫生物科技有限公司 |
检测肿瘤新生抗原多肽的方法和装置
|
|
EP4038222A4
(en)
|
2019-10-02 |
2023-10-18 |
Arizona Board of Regents on behalf of Arizona State University |
METHODS AND COMPOSITIONS FOR IDENTIFYING NEOANTIGENS FOR USE IN THE TREATMENT AND PREVENTION OF CANCER
|
|
US11920202B2
(en)
|
2020-04-09 |
2024-03-05 |
University Of Connecticut |
Unbiased identification of tumor rejection mediating neoepitopes
|
|
US20230183316A1
(en)
*
|
2020-05-12 |
2023-06-15 |
Sumitomo Pharma Co., Ltd. |
Pharmaceutical composition for treating cancer
|
|
WO2021228999A1
(en)
*
|
2020-05-12 |
2021-11-18 |
Institut Curie |
Neoantigenic epitopes associated with sf3b1 mutations
|
|
WO2021252904A1
(en)
|
2020-06-11 |
2021-12-16 |
Massachusetts Institute Of Technology |
Ribonucleoprotein approach to boost the sting signaling for cancer immunotherapy
|
|
IL300026A
(en)
|
2020-08-06 |
2023-03-01 |
Gritstone Bio Inc |
Multiepitope vaccine cassettes
|
|
CA3189285A1
(en)
|
2020-08-13 |
2022-02-17 |
Vikram JUNEJA |
T cell manufacturing compositions and methods
|
|
JP2023539332A
(ja)
*
|
2020-08-31 |
2023-09-13 |
ワールド バイオテック リジェネラティブ メディカル グループ リミテッド |
個別化された免疫原性組成物及びその製造方法及びその使用
|
|
KR102552632B1
(ko)
*
|
2020-11-06 |
2023-07-06 |
사회복지법인 삼성생명공익재단 |
중추신경계 림프종을 진단하기 위한 마커, 이를 포함하는 중추신경계 림프종 진단 키트 및 중추신경계 림프종을 진단하는 방법
|
|
CA3212877A1
(en)
*
|
2021-03-26 |
2022-09-29 |
Sunil Sharma |
Methods and compounds for neoantigen vaccines
|
|
AU2022267777A1
(en)
|
2021-04-30 |
2023-10-05 |
Centre Hospitalier Universitaire Vaudois (Chuv) |
Single vessel expansion of lymphocytes
|
|
WO2022251034A1
(en)
*
|
2021-05-27 |
2022-12-01 |
Amazon Technologies, Inc. |
Multicomponent chemical composition of a peptide-based neoantigen vaccine
|
|
CN117999355A
(zh)
|
2021-08-24 |
2024-05-07 |
生物技术欧洲股份公司 |
体外转录技术
|
|
CN115772564B
(zh)
*
|
2021-09-08 |
2023-08-18 |
广州市基准医疗有限责任公司 |
用于辅助检测肺癌体细胞atm基因融合突变的甲基化生物标记物及其应用
|
|
US20240417805A1
(en)
|
2021-10-21 |
2024-12-19 |
Curevac Netherlands B.V. |
Cancer neoantigens
|
|
CN116287158A
(zh)
*
|
2021-12-08 |
2023-06-23 |
初源海生物科技(深圳)有限公司 |
一种新抗原鉴定和疗效预测方法
|
|
KR20240161965A
(ko)
|
2022-03-14 |
2024-11-13 |
제너레이션 바이오 컴퍼니 |
이종 프라임 부스트 백신 조성물 및 사용 방법
|
|
WO2024077256A1
(en)
|
2022-10-07 |
2024-04-11 |
The General Hospital Corporation |
Methods and compositions for high-throughput discovery ofpeptide-mhc targeting binding proteins
|
|
WO2024083345A1
(en)
|
2022-10-21 |
2024-04-25 |
BioNTech SE |
Methods and uses associated with liquid compositions
|
|
KR20250144510A
(ko)
|
2022-11-02 |
2025-10-10 |
티젠 파마 에스에이 |
림프구 확장
|
|
EP4474016A1
(en)
|
2023-06-07 |
2024-12-11 |
Julius-Maximilians-Universität Würzburg |
Strategies to target extracellularly accessible ras protein
|
|
WO2024261339A1
(en)
|
2023-06-23 |
2024-12-26 |
Tigen Pharma Sa |
Lymphocyte-stimulatory matrix (lsm) and uses thereof for expansion of lymphocyte populations
|
|
WO2025202937A1
(en)
|
2024-03-26 |
2025-10-02 |
BioNTech SE |
Cancer vaccines
|